Breast cancer in a multi-ethnic Asian setting: Results from the Singapore-Malaysia hospital-based breast cancer registry

Breast

Volumn 20, Issue SUPPL. 2, 2011, Pages

  Bhoo Pathy, Nirmala ^a,b,c   Yip, Cheng Har ^a   Taib, Nur Aishah ^a   Hartman, Mikael ^d,e   Saxena, Nakul ^d   Iau, Philip ^d   Bulgiba, Awang M ^a   Lee, Soo Chin ^f   Lim, Siew Eng ^f   Wong, John E L ^g   Verkooijen, Helena M ^b,d  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c MINISTRY OF HEALTH   (Malaysia)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^e KAROLINSKA INSTITUTE   (Sweden)

^f NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^g NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

Asia; Asian; Breast cancer; Cancer registry

Indexed keywords

ANTINEOPLASTIC AGENT; ESTROGEN RECEPTOR;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; ASIAN; BREAST CANCER; BREAST CARCINOGENESIS; BREAST DUCT; CANCER CENTER; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; CHINESE; COHORT ANALYSIS; CONSERVATIVE TREATMENT; CONTROLLED STUDY; ETHNICITY; FEMALE; HISTOPATHOLOGY; HORMONAL THERAPY; HUMAN; HUMAN TISSUE; INDIA; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALAYSIA; MALE; MASTECTOMY; OVERALL SURVIVAL; PRIORITY JOURNAL; SINGAPORE; TUMOR VOLUME; UNIVERSITY HOSPITAL;

EID: 79953063689     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2011.01.015     Document Type: Article

References (32)

1. Ravdin P.M., Cronin K.A., Howlader N., Berg C.D., Chlebowski R.T., Feuer E.J., et al. The decrease in breast cancer incidence in 2003 in the United States. N Eng J Med 2007, 356(16):1670-1674.
2. Fontenoy A.M., Leux C., Billon S.D., Allioux C., Frenel J.S., Campone M., et al. Recent trends in breast cancer incidence rates in the Loire-Atlantique, France: a decline since 2003. Cancer Epidemiol 2010, 34(3):238-243.
3. Wang P.P., Cao Y. Incidence trends of female breast cancer in Saskatchewan, 1932-1990. Breast Cancer Res Treat 1996, 37:197-207.
4. Sim X., Ali A., Wedren S., Goh D.L.M., Tan C.S., Reilly M., et al. Ethnic differences in time trend of female breast cancer incidence: Singapore, 1968-2002. BMC Cancer 2006, 6:261. 10.1186/1471-2407-6-261.
5. Medina V.M., Laudico A., Mirasol-Lumague M.R., Brenner H., Redaniel M.T. Cumulative incidence trends of selected cancer sites in a Philippine population from 1983 to 2002: a joinpoint analysis. Br J Cancer 2010, 102(9):1411-1414.
6. Takiar R., Srivastav A. Time trend in breast and cervix cancer of women in India (1990-2003). Asian P J Cancer Prev 2008, 9(4):777-780.
7. Hirabayashi Y., Zhang M. Comparison of time trends in breast cancer incidence (1973-2002) in Asia, from cancer incidence in five continents, Vols IV-IX. JPN J Clin Oncol 2009, 39(6):411-412.
8. Lim S.E., Back M., Quek E., Iau P., Putti T., Wong J.E.L. Clinical observations from a breast cancer registry in Asian women. World J Surg 2007, 31:1387-1392. 10.1007/s00268-007-9086-3.
9. Smigal C., Jemal A., Ward E., Cokkinides V., Smith R., Howe H.L., et al. Trends in breast cancer by race and ethnicity. CA Cancer J Clin 2006, 56:168-183. 10.3322/canjclin.56.3.168.
10. Chia K.S., Lee J.J., Wong J.L., Gao W., Lee H.P., Shanmugaratnam K. Cancer incidence in Singapore 1998-1999. Ann Acad Med Singapore 2002, 31:745-750.
11. Agarwal G., Pradeep P.V., Aggarwal V., Yip C.H., Cheung P.S.Y. Spectrum of breast cancer in Asian women. World J Surg 2007, 31:1031-1040.
12. Sant M., Allemani C., Berrino F., Coleman M.P., Aareleid T., Chaplain G., et al. Breast carcinoma srvival in Europe and the United States. A population based study. Cancer 2004, 100(4):715-722.
13. Miller B.A., Hankey B.F., Thomas T.L. Impact of sociodemographic factors, hormone receptor status, and tumor grade on ethnic differences in tumor stage and size for breast cancer in US women. Am J Epidemiol 2002, 155:534-545.
14. Li C.I., Malone K.E., Porter P.L., Lawton T.J., Voigt L.F., Cushing-Haugen K.L., et al. Relationship between menopausal hormone therapy and risk of ductal, lobular and ductal-lobular breast carcinomas. Cancer Epidemiol Biomarkers Prev 2008, 17(1):43-50.
15. Verkooijen H.M., Fioretta G., Vlastos G., Morabia A., Schubert H., Sappino A.P. Important increase of invasive lobular breast cancer incidence in Geneva, Switzerland. Int J Cancer 2003, 104(6):778-781.
16. Huang K.E., Xu L., Nasri N., Jaisamrarn U. The Asian Menopause Survey. Knowledge, perceptions, hormone treatment and sexual function. Maturitas 2010, 65(3):276-283.
17. Verkooijen H.M., Bouchardy C., Vinh-Hung V., Rapiti E., Hartman M. The incidence of breast cancer and changes in the use of hormone replacement therapy: a review of evidence. Maturitas 2009, 64(2):80-88.
18. Dunnwald L.K., Rossing M.A., Li C.I. Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients. Breast Cancer Res 2007, 9:R6. 10.1186/bcr1639.
19. Colditz G.A., Rosner B.A., Chen W.Y., Holmes M.D., Hankinson S.E. Risk factors for breast cancer according to estrogen and progesterone receptor status. JNCI J Natl Cancer Inst 2004, 96(3):218-228.
20. Chen W.Y., Hankinson S.E., Schnitt S.J., Rosner B.A., Holmes M.D., Colditz G.A. Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma. Cancer 2004, 101(7):1490-1500.
21. Katipamula R., Degnim A.C., Hoskin T., Boughey J.C., Loprinzi C., Grant C.S., et al. Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging. J Clin Oncol 2009, 27:4082-4088.
22. Lazovich D., Solomon C.C., Thomas D.B., Moe R.E., White E. Breast conservation therapy in the United States following the 1990 National Institutes of Health Consensus Development Conference on the treatment of patients with early stage invasive breast carcinoma. Cancer 1999, 86(4):628-637.
23. Chen Z., Wu A.H., Gauderman W.J., Bernstein L., Ma H., Pike M.C., et al. Does mammographic density reflect ethnic differences in breast cancer incidence rates?. Am J Epidemiol 2004, 159:140-147.
24. Leong B.D.K., Chuah J.A., Kumar V.M., Rohamini S., Siti Z.S., Yip C.H. Trends of breast cancer treatment in Sabah, Malaysia: a problem with lack of awareness. Singapore Med J 2009, 50(8):772-776.
25. Kirby R.M., Basit A., Manimaran N. Patient choice significantly affects mastectomy rates in the treatment of breast cancer. Int Semin Surg Oncol 2008, 5:20. 10.1186/1477-7800-5-20.
26. Katz S.J., Lantz P.M., Janz N.K., Fagerlin A., Schwartz K., Liu L., et al. Patient involvement in surgery treatment decisions for breast cancer. J Clin Oncol 2005, 23:5526-5533.
27. Ng W., Delaney G.P., Jacob S., Barton M.B. Estimation of an optimal chemotherapy utilization rate for breast cancer: setting an evidence-based bench mark for the best quality cancer care. Eur J Cancer 2010, 46(4):703-712.
28. Hisham A.N., Yip C.H. Overview of breast cancer in Malaysian women: a problem with late diagnosis. Asian J Surg 2004, 27:130-133.
29. Hyodo I., Amano N., Eguchi K., Narabayashi M., Imanishi J., Hirai M., et al. Nationwide survey on complementary and alternative medicine in cancer patients in Japan. J Clin Oncol 2005, 23(12):2645-2654.
30. Cui Y., Shu X.O., Gao Y., Wen W., Ruan Z.X., Jin F., et al. Use of complementary and alternative medicine by Chinese women with breast cancer. Breast Cancer Res Treat 2004, 85:263-270.
31. Hisham A.N., Yip C.H. Spectrum of breast cancer in Malaysian women: overview. World J Surg 2003, 27(8):921-923.
32. Verkooijen H.M., Fioretta G.M., Rapiti E., Bonnefoi H., Vlastos G., Kurtz J., et al. Patients' refusal of surgery strongly impairs breast cancer survival. Ann Surg 2005 Aug, 242(2):276-280.